Connection between 1 Year involving Way of life Input about Institutionalized Older Adults

Also, studies had shown that people with respiratory diseases caused by tobacco use are at higher risk of developing severe COVID-19 symptoms. Studies have shown that in vitro, the acute exposure allows for more severe proximal airway epithelial disease from SARS-CoV-2 by reducing the mucosal innate immune response and the proliferation of airway basal stem cells and has implications for disease spread and severity in people exposed to cigarette smoke, with a more severe viral infection and cell death. Smoker patients with different comorbidities are at higher risk of contracting the COVID-19 virus and have a worse prognosis for the virus as well as for their comorbidities. GPR84 antagonist 8 price Further investigations of the interaction between smoking and COVID-19 are warranted to accurately assess the risk of contracting COVID-19 among smokers, and the progression to mechanical ventilation or death in patients who suffer from it.
Smoking history and its potential association with COVID-19 has attracted many researchers and the lay public alike. However, the studies published to date have several methodological limitations and are mainly from China. We set out to synthesize evidence on smoking and COVID-19 relationship drawn on cohort studies only which are published in non-Chinese population settings.
A systematic literature search was undertaken drawn on predefined eligibility criteria and a comprehensive search strategy following the PRISMA guideline between January 2020 and August 2020, excluding preprints and gray literature. Three specific outcomes were examined smoking history, SARS-CoV2 infection, and COVID-19 severity.
Of an eligible 40 full-text studies, 7 cohort studies outside of China were finally included in this literature review through independent reviewing. Four studies were from the UK, 2 from the United States, and 1 from Turkey. The sample size ranged from 200 to more than 5000 participants. The findings broadly point to 1 direction, a higher smoking prevalence and an increased risk of smoking history on both SARS-CoV2 infection and on COVID-19 severity.
A smoking history (either current or past) seems to negatively impact both SARS-CoV2 infection and COVID-19 severity. However, such an observation strengthens the argument to continue smoking cessation efforts both for individuals and for the general population health and well-being.
A smoking history (either current or past) seems to negatively impact both SARS-CoV2 infection and COVID-19 severity. However, such an observation strengthens the argument to continue smoking cessation efforts both for individuals and for the general population health and well-being.
Healthy internet activity (eg, making use of eHealth and online therapy) is positively associated with well-being. However, unhealthy internet activity (too much online time, problematic internet use/PIU, internet dependency/ID, etc.) is associated with reduced well-being, loneliness, and other related negative aspects. While most of the evidence is correlational, some research also shows that internet activity can be predictive for well-being.
The aim of this article is to elaborate on the question as to what extent internet activity is predictive of psychological well-being by means of (a) a scoping review and (b) theoretical understanding which model the interrelation of internet activity and psychological well-being.
We searched different electronic databases such as Web of Science by using the search terms "Internet" OR "App" OR "digital" OR "online" OR "mobile application" AND "Use" OR "Activity" OR "Behavior" OR "Engagement" AND "Well-being" OR "Loneliness" for (a, the scoping review) or CCAM forly aim at preventing problematic internet use and internet dependency.
Depressive symptoms related to workplace violence (WPV) have been studied and are the main causes of lower psychological and physical well-being and work motivation. Our study aims to examine the prevalence of depressive symptoms and to explore whether psychological capital (PsyCap) mediates the effect of WPV on depressive symptoms in doctors and nurses.
Participants were recruited from general hospitals in Liaoning, China in 2018. Out of 1218 participants, 1062 (87.2%) completed self-reported questionnaires. Depressive symptoms, WPV and PsyCap were measured by Epidemiologic Studies Depression Scale (CES-D), Workplace Violence Scale (WVS) and Psychological Capital Questionnaire (PCQ), respectively. The related factors of depressive symptoms were investigated by using hierarchical multiple regression in both doctors and nurses.
The mean scores of depressive symptoms were 23.09 ± 8.38 in doctors and 22.33 ± 8.95 in nurses, and there was no significant difference between the scores of these two groups. WPV was positively associated with depressive symptoms (doctors
=0.349,
<0.001; nurses
=0.317,
<0.001) while PsyCap was negatively associated with depressive symptoms (doctors
=-0.101,
<0.001; nurses
=-0.230,
<0.001). In addition, PsyCap acted as a mediating role between WPV and depressive symptoms in both doctors and nurses.
Both doctors and nurses had serious depressive symptoms. WPV could aggravate depressive symptoms, while PsyCap could aggravate against depressive symptoms. When PsyCap acted as a mediator, WPV had a negative impact on PsyCap, which could increase doctors' and nurses' depressive symptoms.
Both doctors and nurses had serious depressive symptoms. WPV could aggravate depressive symptoms, while PsyCap could aggravate against depressive symptoms. When PsyCap acted as a mediator, WPV had a negative impact on PsyCap, which could increase doctors' and nurses' depressive symptoms.
Cervical cancer is the second most common type of cancer and cause of death from cancer in Indonesia. In 2013, cervical cancer was the most prevalent cancer in Indonesia, with a rate of 0.8 per 1000 women. Based on the National Guidelines for Cervical Cancer Medical Services in Indonesia, the recommended therapy for stages IIB-IIIB cervical cancer is chemoradiation or radiotherapy. This study aimed to evaluate the cost-effectiveness of chemoradiation and radiotherapy for treating stage IIB-IIIB cervical cancer in a national referral hospital in Indonesia.
A cross-sectional study from a healthcare perspective using retrospective patient data was conducted. The included patients had stage IIB-IIIB registered cervical cancer, were in the hospital between January 1, 2015 and December 31, 2017, received chemoradiation or radiotherapy, were ≥18 years old, and had complete clinical data and detailed cost of therapy data. The incremental cost-effectiveness ratio (ICER) were calculated, and a sensitivity analysis was performed.